CCRN - Cross Country Healthcare, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Boca Raton,
United States
Type: Equity
CCRN price evolution
CCRN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.09 | $14.3 | $0.67 | $0.29 |
| Short term investments | ||||
| Net receivables | $407.16 | $440.51 | $492.71 | $634.34 |
| Inventory | ||||
| Total current assets | $415.15 | $445.23 | $505.63 | $648.61 |
| Long term investments | ||||
| Property, plant & equipment | $29.94 | $28.89 | $27.15 | $25.59 |
| Goodwill & intangible assets | $189.9 | $192.69 | $197.19 | $204.61 |
| Total noncurrent assets | $264.16 | $262.51 | $265.5 | $271.93 |
| Total investments | ||||
| Total assets | $679.32 | $707.74 | $771.13 | $920.54 |
| Current liabilities | ||||
| Accounts payable | $85.33 | $114.8 | $139.56 | $176.88 |
| Deferred revenue | ||||
| Short long term debt | $2.6 | $2.78 | $3.29 | $3.58 |
| Total current liabilities | $148.59 | $183.58 | $216.03 | $264.91 |
| Long term debt | $2.66 | $3.04 | $34.15 | $142.29 |
| Total noncurrent liabilities | $57.34 | $54.5 | $84.75 | $203.7 |
| Total debt | $5.27 | $5.82 | $37.44 | $145.87 |
| Total liabilities | $205.92 | $238.08 | $300.78 | $468.61 |
| Shareholders' equity | ||||
| Retained earnings | $238.36 | $229.32 | $216.51 | $195.16 |
| Other shareholder equity | -$1.39 | -$1.39 | -$1.38 | -$1.38 |
| Total shareholder equity | $473.39 | $469.66 | $470.35 | $451.93 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.09 | $3.6 | $1.04 | $1.6 |
| Short term investments | ||||
| Net receivables | $407.16 | $659.96 | $498.95 | $174.7 |
| Inventory | ||||
| Total current assets | $415.15 | $675.67 | $508.27 | $183.11 |
| Long term investments | ||||
| Property, plant & equipment | $29.94 | $22.93 | $23.32 | $22.8 |
| Goodwill & intangible assets | $189.9 | $207.99 | $167.73 | $131.66 |
| Total noncurrent assets | $264.16 | $272.17 | $224.54 | $173.86 |
| Total investments | ||||
| Total assets | $679.32 | $947.84 | $732.81 | $356.97 |
| Current liabilities | ||||
| Accounts payable | $85.33 | $158.45 | $109.75 | $49.88 |
| Deferred revenue | ||||
| Short long term debt | $2.6 | $4.13 | $8.27 | $4.51 |
| Total current liabilities | $148.59 | $271.64 | $199.77 | $93.42 |
| Long term debt | $2.66 | $148.74 | $187.22 | $68.64 |
| Total noncurrent liabilities | $57.34 | $218.98 | $235.51 | $108.64 |
| Total debt | $5.27 | $157.75 | $195.49 | $73.15 |
| Total liabilities | $205.92 | $490.62 | $435.28 | $202.06 |
| Shareholders' equity | ||||
| Retained earnings | $238.36 | $165.73 | -$22.73 | -$154.74 |
| Other shareholder equity | -$1.39 | -$1.39 | -$1.29 | -$1.28 |
| Total shareholder equity | $473.39 | $457.22 | $297.53 | $154.38 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $414.04 | $442.29 | $540.7 | $622.71 |
| Cost of revenue | $323.55 | $344.93 | $417.56 | $483.28 |
| Gross Profit | $90.49 | $97.36 | $123.14 | $139.42 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $67.57 | $69.63 | $78.94 | $84.26 |
| Total operating expenses | $77.06 | $77.06 | $87.95 | $95.63 |
| Operating income | $13.42 | $20.3 | $35.19 | $43.8 |
| Income from continuing operations | ||||
| EBIT | $13.55 | $20.17 | $33.45 | $43.81 |
| Income tax expense | $3.93 | $6.69 | $8.96 | $10.68 |
| Interest expense | $0.59 | $0.67 | $3.15 | $3.69 |
| Net income | ||||
| Net income | $9.04 | $12.81 | $21.34 | $29.44 |
| Income (for common shares) | $9.04 | $12.81 | $21.34 | $29.44 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2019.73 | $2806.61 | $1676.65 | $836.42 |
| Cost of revenue | $1569.32 | $2178.92 | $1301.65 | $633.68 |
| Gross Profit | $450.41 | $627.69 | $375 | $202.73 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $300.39 | $324.21 | $215.29 | $173.81 |
| Total operating expenses | $337.7 | $354.58 | $235.69 | $211.89 |
| Operating income | $112.71 | $273.11 | $139.3 | -$9.16 |
| Income from continuing operations | ||||
| EBIT | $110.99 | $270.72 | $140.07 | -$10.26 |
| Income tax expense | $30.26 | $67.86 | $1.21 | -$0.19 |
| Interest expense | $8.09 | $14.39 | $6.87 | $2.89 |
| Net income | ||||
| Net income | $72.63 | $188.46 | $132 | -$12.96 |
| Income (for common shares) | $72.63 | $188.46 | $132 | -$12.96 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $9.04 | $12.81 | $21.34 | $29.44 |
| Operating activities | ||||
| Depreciation | $4.76 | $4.83 | $4.71 | $5.16 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.17 | $1.43 | $2.21 | $1.77 |
| Total cash flows from operations | $12.07 | $70.31 | $119.25 | $46.87 |
| Investing activities | ||||
| Capital expenditures | -$2.88 | -$3.42 | -$4 | -$3.68 |
| Investments | ||||
| Total cash flows from investing | -$2.88 | -$3.41 | -$4 | -$3.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$6.4 | -$14.77 | -$4.72 | -$31.76 |
| Net borrowings | -$31 | -$109.28 | -$10.4 | |
| Total cash flows from financing | -$6.42 | -$53.27 | -$114.87 | -$46.68 |
| Effect of exchange rate | $0.01 | -$0 | $0 | -$0 |
| Change in cash and equivalents | $2.79 | $13.63 | $0.38 | -$3.31 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $72.63 | $188.46 | $132 | -$12.96 |
| Operating activities | ||||
| Depreciation | $19.46 | $14.43 | $12.28 | $16.22 |
| Business acquisitions & disposals | -$35.18 | -$26.88 | ||
| Stock-based compensation | $6.58 | $7.39 | $6.89 | $5.4 |
| Total cash flows from operations | $248.5 | $134.05 | -$85.62 | $27.2 |
| Investing activities | ||||
| Capital expenditures | -$13.97 | -$8.79 | -$7.17 | -$4.62 |
| Investments | ||||
| Total cash flows from investing | -$13.78 | -$43.87 | -$34.05 | -$4.62 |
| Financing activities | ||||
| Dividends paid | -$1.15 | |||
| Sale and purchase of stock | -$57.65 | -$35.28 | ||
| Net borrowings | -$150.68 | -$38.5 | $121.58 | -$20.07 |
| Total cash flows from financing | -$221.24 | -$87.6 | $119.09 | -$22.01 |
| Effect of exchange rate | $0.01 | -$0.01 | $0.01 | -$0.01 |
| Change in cash and equivalents | $13.49 | $2.57 | -$0.56 | $0.57 |
News
Fundamentals
| Market cap | $593.35M |
|---|---|
| Enterprise value | $581.52M |
| Shares outstanding | 35.15M |
| Revenue | $2.02B |
|---|---|
| EBITDA | $130.45M |
| EBIT | $110.99M |
| Net Income | $72.63M |
| Revenue Q/Q | -34.09% |
| Revenue Y/Y | N/A |
| P/E ratio | 8.17 |
|---|---|
| EV/Sales | 0.29 |
| EV/EBITDA | 4.46 |
| EV/EBIT | 5.24 |
| P/S ratio | 0.29 |
| P/B ratio | 1.25 |
| Book/Share | 13.51 |
| Cash/Share | 0.49 |
| EPS | $2.07 |
|---|---|
| ROA | 9.44% |
| ROE | 15.57% |
| Debt/Equity | 0.43 |
|---|---|
| Net debt/EBITDA | 1.45 |
| Current ratio | 2.79 |
| Quick ratio | 2.79 |